Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 95

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

Location: Centre Hospitalier Universitaire de la Guadeloupe Les Abymes Guadeloupe

Summary

Hepatitis E is well known to be a common cause of severe hepatitis on organ-transplanted people. However, several studies also show a risk of transition to a chronic state. It is necessary to carry out a preliminary study in order to determine the hepatitis E prevalence in the population of the French West Indies. The aim of our study is to make a systematic screening of the hepatitis E within this risk population; hepatic and renal transplanted people. Up to now, no severe hepatitis E case was reported in the French West Indies. We would like to know if the systematic screening will change or not, this assumption.

Eligibility Criteria

Inclusion Criteria: * age above 18 years * patients with liver or kidney transplant * health insurance Exclusion Criteria: * minor * pregnant or breastfeeding women * vulnerable person

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07729202). StuddyBuddy aggregates publicly available trial information.